gunnercooke corporate partners David Salamons and Harriet Collins have successfully advised the shareholders of Mymedsandme Limited on the sale of the company to Stanley Capital Partners LLP (SCP), a European and US-focused mid-market private equity firm.
Mymeds&Me capture safety data directly from patients, healthcare professionals and Pharma clients through its global SaaS platform, Reportum®. MMM has a broad, well-established, and global client base, which includes some of the world’s leading pharmaceutical companies.
The acquisition of the digital-first organisation will strengthen the offering of a best-in-class pharmacovigilance solution focused on the current and future requirements of the life sciences industry.
The financial terms of the acquisition are not being disclosed.
David and Harriet were assisted by gunnercooke corporate Partner Mark Langford and supported by trainee solicitor Shabab Ahmed.
Harriet commented: “it was great to work with the founders and shareholders of Mymedsandme on this exciting transaction in the pharmacovigilance space and secure positive outcome for those involved.”